2015 Overseer and HAA Director Nominees

The official candidate slates

This spring, alumni can vote for five new Harvard Overseers and six new elected directors of the Harvard Alumni Association (HAA).

Ballots, mailed out by April 1, must be received back in Cambridge by noon on May 22 to be counted. Election results will be announced at HAA’s annual meeting on May 28, on the afternoon of Commencement day. All holders of Harvard degrees, except Corporation members and officers of instruction and government, are entitled to vote for Overseer candidates. The election for HAA directors is open to all Harvard degree-holders.

Candidates for Overseer may also be nominated by petition by obtaining a prescribed number of signatures from eligible degree-holders. (The deadline for all petitions is February 2.)

For Overseer (six-year term):

R. Martin Chavez ’85, S.M. ’85, New York City. CIO and partner, The Goldman Sachs Group, Inc.

Fernande R. V. Duffly, J.D. ’78, Boston. Associate Justice, Massachusetts Supreme Judicial Court.

Sandra Edgerley ’84, M.B.A. ’89, Brookline, Massachusetts. Nonprofit strategist and community volunteer.

Brian Greene ’84, New York City. Professor of physics and mathematics, Columbia University.

Beth Y. Karlan ’78, M.D. ’82, Los Angeles. Director, Women’s Cancer Program, Samuel Oschin Comprehensive Cancer Institute; director, division of gynecologic oncology, department of obstetrics and gynecology, Cedars-Sinai Medical Center; and professor of obstetrics and gynecology, David Geffen School of Medicine at UCLA.

Carl F. Muller ’73, J.D.-M.B.A. ’76, Greenville, South Carolina. Attorney.

David B. Weinberg ’74, Chicago. Chairman and CEO, Judd Enterprises, Inc.

John Silvanus Wilson Jr., M.T.S. ’81, Ed.D. ’82, Ed.D. ’85. Atlanta. President, Morehouse College.

 

For elected director (three-year term):

Krzysztof Daniewski, M.B.A. ’99, Warsaw. President, Ivy Poland Foundation.

Paige Ennis, M.P.A. ’10, Washington, D.C. Vice president, office of external relations, Atlantic Council.

Ellen M. Guidera, M.B.A. ’86, Santiago, Chile. Investor and director, Portillo Ski Resort and Tierra Hotels.

Andrew Herwitz ’83, J.D. ’90, New York City. President, The Film Sales Company.

Sharon E. Jones ’77, J.D. ’82, Chicago. President and CEO, OH Community Partners.

William R. Koehler ’87, Shaker Heights, Ohio. Senior financial services executive.

Tracy “Ty” Moore II ’06, Oakland, California. Co-founder, MindBlown Labs.

Anders Yang, J.D. ’94, Irvine, California. Assistant dean, office of external relations, The Paul Merage School of Business, University of California, Irvine.

Ariel Zwang ’85, M.B.A. ’90, New York City. CEO, Safe Horizon.

Related topics

You might also like

Three Harvard Alumni and a Former Postdoc Named MacArthur Fellows

A labor economist, an organic chemist, a physicist, and a memory researcher were honored with 2026 “genius” grants.

Thank You, Bill Kirby

The president of Harvard Magazine’s Board of Directors will step down in September.

Meet the Harvard Alumni Association’s New President

David Battat promotes alumni engagement.

Most popular

Harvard Alumni Win Two 2026 Nobel Prizes

Karl Deisseroth revolutionized neuroscience. Navanethem “Navi” Pillay has adjudicated cases in international courts concerning genocide.

Harvard Weathers a Year of Turmoil

The federal government has launched unprecedented actions against the University. Here’s a guide.

Lafayette’s Unexpected Gift to George Washington: Pheasants

The two birds will be on display at Harvard this summer.

Explore More From Current Issue

University Hall with steps and the John Harvard statue, surrounded by trees and a grassy lawn.

Long-discussed reorganization includes layoffs and the end of the Dudley Community.

Decorative wrought iron gate framed by leafy branches, captured in sepia tones.

Former Indiana University president Thomas Ehrlich looks back on curriculum, co-education, and other major trends.

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.